Lung Cancer Treatment and Research /

This book describes the molecular mechanisms of lung cancer development and progression that determine therapeutic interventions in the era of genomics, when the rapid evolution in lung cancer diagnosis and treatment necessitates critical review of new results to integrate advances into practice.  T...

Full description

Corporate Author: SpringerLink (Online service)
Other Authors: Reckamp, Karen L. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2016.
Edition:1st ed. 2016.
Series:Cancer Treatment and Research, 170
Subjects:
Online Access:https://doi.org/10.1007/978-3-319-40389-2
LEADER 03558nam a22005175i 4500
001 978-3-319-40389-2
003 DE-He213
005 20210617043609.0
007 cr nn 008mamaa
008 160817s2016 gw | s |||| 0|eng d
020 |a 9783319403892  |9 978-3-319-40389-2 
024 7 |a 10.1007/978-3-319-40389-2  |2 doi 
050 4 |a RC254-282 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
082 0 4 |a 616.994  |2 23 
245 1 0 |a Lung Cancer  |h [electronic resource] :  |b Treatment and Research /  |c edited by Karen L. Reckamp. 
250 |a 1st ed. 2016. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2016. 
300 |a VI, 322 p. 14 illus., 9 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Cancer Treatment and Research,  |x 0927-3042 ;  |v 170 
505 0 |a Lung cancer biology -- Screening and prevention -- Diagnosis and molecular classification -- Staging and prognosis -- Treatment—Surgery -- Treatment—Radiation therapy -- Treatment—Chemotherapy.-  Treatment—Multimodality therapy -- Targeted therapy -- Resistance to therapy -- Immunotherapy -- Palliative and supportive care.-  Geriatric oncology --  Multidisciplinary care -- Small cell lung cancer. 
520 |a This book describes the molecular mechanisms of lung cancer development and progression that determine therapeutic interventions in the era of genomics, when the rapid evolution in lung cancer diagnosis and treatment necessitates critical review of new results to integrate advances into practice.  The text opens with background and emerging information regarding the molecular biology of lung cancer pathogenesis.  Updated results regarding lung cancer prevention and screening are discussed, followed by chapters on diagnostic techniques and pathological evaluation.  This leads on to a detailed presentation of treatment modalities, from surgery and radiation therapy to standard chemotherapy and targeted agents. The coverage includes resistance to therapy and the emergence of immunotherapy for lung cancer; in addition, the current evidence in respect of small cell lung cancer is summarized.  The book presents insights from experts across disciplines to emphasize the importance of collaborative care.  Advances in our understanding of issues in geriatric oncology and palliative care complete the comprehensive discussion of lung cancer. 
650 0 |a Oncology  . 
650 0 |a Thoracic surgery. 
650 0 |a Radiotherapy. 
650 1 4 |a Oncology.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/H33160 
650 2 4 |a Thoracic Surgery.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/H59095 
650 2 4 |a Radiotherapy.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/H29056 
700 1 |a Reckamp, Karen L.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783319403878 
776 0 8 |i Printed edition:  |z 9783319403885 
776 0 8 |i Printed edition:  |z 9783319820910 
830 0 |a Cancer Treatment and Research,  |x 0927-3042 ;  |v 170 
856 4 0 |u https://doi.org/10.1007/978-3-319-40389-2 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714)